What's New :
CSE QUALIFIER 2026: Complete Prelims & Mains Readiness through Daily Tests & Mentorship
27th August 2025 (18 Topics)

Gold Nanoclusters for Parkinson’s Detection

Context:

Researchers at INST, Mohali, have developed a gold nanocluster–based biosensor for early detection of Parkinson’s disease.

Parkinson’s Disease (PD):

  • PD is one of the fastest-growing neurological disorders globally.
  • It involves progressive degeneration of dopaminergic neurons, leading to motor and non-motor symptoms.
  • Diagnosis generally occurs only after considerable neuronal loss, making early detection critical.

Key Protein – ?-synuclein:

  • In PD, ?-synuclein undergoes misfolding and aggregation.
  • Normal form is harmless (monomeric), while aggregated form (amyloid) is toxic and damages brain cells.

Nanotechnology Application – Gold Nanoclusters (AuNCs):

  • Ultra-small fluorescent particles (few nanometers wide).
  • Amino acid–capped nanoclusters (Proline-coated ? normal protein; Histidine-coated ? toxic protein aggregates).
  • Used to distinguish between physiological and pathological protein conformers.

Techniques Used:

  • UV-Vis spectroscopy, fluorescence imaging, TEM, XPS.
  • Gel electrophoresis, fluorescence quenching, cyclic voltammetry, impedance spectroscopy.
  • Tested in SH-SY5Y human neuroblastoma cells to validate biosafety and effectiveness.

Institutional Framework:

  • Research carried out at Institute of Nano Science and Technology (INST), Mohali, under the Department of Science and Technology (DST).
  • Collaboration with CSIR-Institute of Microbial Technology (IMTECH), Chandigarh for protein biochemistry and cell-based assays.

Significance:

  • Provides a label-free, low-cost, clinically adaptable biosensor for early detection of PD.
  • Potential extension to other protein-misfolding diseases like Alzheimer’s.
  • Supports India’s focus on affordable healthcare, nanotechnology, and biotechnology innovation.

Verifying, please be patient.

Enquire Now